| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |